Oral transmission of HIV, reality or fiction? An update (Q34526020)

2 August 2017

1 reference

title

Oral transmission of HIV, reality or fiction? An update (English)

1 reference

2 August 2017

0 references

Campo J

1 reference

2 August 2017

Perea MA

1 reference

2 August 2017

del Romero J

1 reference

2 August 2017

Cano J

1 reference

2 August 2017

Hernando V

1 reference

2 August 2017

Bascones A

1 reference

2 August 2017

publication date

1 May 2006

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

2 August 2017

page(s)

219-228

1 reference

In Situ Detection of Hepatitis C Virus RNA in Salivary Glands

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: a comparison by site and correlation with clinical information

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

An outbreak no longer: factors contributing to the return of syphilis in Greater Manchester

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Why is HIV rarely transmitted by oral secretions? Saliva can disrupt orally shed, infected leukocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Oral transmission of human immunodeficiency virus by infected seminal fluid and milk: a novel mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Practical prevention of vaginal and rectal transmission of HIV by adapting the oral defense: use of commercial lubricants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Genital herpes infection: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Oral mucosal immunity and HIV infection: current status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Alcohol enhances HIV type 1 infection in normal human oral keratinocytes by up-regulating cell-surface CXCR4 coreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Minidefensins: antimicrobial peptides with activity against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Identification of a CD36-related Thrombospondin 1–binding Domain in HIV-1 Envelope Glycoprotein gp120: Relationship to HIV-1–specific Inhibitory Factors in Human Saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Identification of a major co-receptor for primary isolates of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Crack cocaine smoking and oral sores in three inner-city neighborhoods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Components of saliva inactivate human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Infectious human immunodeficiency virus can rapidly penetrate a tight human epithelial barrier by transcytosis in a process impaired by mucosal immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Mother-to-child transmission of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Lysozyme and RNases as anti-HIV components in beta-core preparations of human chorionic gonadotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Salivary secretory leukocyte protease inhibitor increases in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Human immunodeficiency virus type 1 infection and replication in normal human oral keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Oral diagnostic testing for detecting human immunodeficiency virus-1 antibodies: a technology whose time has come.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Possible female-to-female transmission of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Assessment of oral transmission using cell-free human immunodeficiency virus-1 in mice reconstituted with human peripheral blood leucocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

High numbers of T cells in gingiva from patients with human immunodeficiency virus (HIV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Periodontal diseases: pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Sexual risk behavior and risk factors for HIV-1 seroconversion in homosexual men participating in the Tricontinental Seroconverter Study, 1982-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Orogenital transmission of human immunodeficiency virus (HIV)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Secretory leukocyte protease inhibitor in vaginal fluids and perinatal human immunodeficiency virus type 1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Pre-ejaculatory fluid as potential vector for sexual transmission of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Infection of oral mucosal cells by human immunodeficiency virus type 1 in seropositive persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Detection of HIV in oral mucosal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Parotid salivary basic proline-rich proteins inhibit HIV-I infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Evaluating the risk of HIV transmission through unprotected orogenital sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Oral transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Sexual transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Endogenous mucosal antiviral factors of the oral cavity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

The role of the oral environment in HIV-1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Saliva and inhibition of HIV-1 infection: molecular mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Inhibitory function of secretory leukocyte proteinase inhibitor (SLPI) in human saliva is HIV-1 specific and varies with virus tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Interaction of the envelope glycoprotein of human immunodeficiency virus with C1q and fibronectin under conditions present in human saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Detection of IgA inhibiting the interaction between gp120 and soluble CD4 receptor in serum and saliva of HIV-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Virucidal effects of glucose oxidase and peroxidase or their protein conjugates on human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Patients infected with human immunodeficiency virus type 1 have low levels of virus in saliva even in the presence of periodontal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

Inhibition of HIV-1 Production and Selective Degradation of Viral RNA by an Amphibian Ribonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2005.01187.X

10.1111/J.1601-0825.2005.01187.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference